Literature DB >> 33440203

Phasic Versus Tonic Irritability: Differential Associations With Attention-Deficit/Hyperactivity Disorder Symptoms.

Elise M Cardinale1, Gabrielle F Freitag2, Melissa A Brotman2, Daniel S Pine2, Ellen Leibenluft2, Katharina Kircanski2.   

Abstract

OBJECTIVE: Irritability is a multifaceted construct in pediatric psychopathology. It has been conceptualized as having a phasic dimension and a tonic dimension. Disruptive mood dysregulation disorder is defined by the presence of both dimensions. Severe irritability, or disruptive mood dysregulation disorder, is highly comorbid with attention-deficit/hyperactivity disorder (ADHD). However, it is unknown whether the presence of ADHD modulates the expression of phasic and tonic irritability.
METHOD: A data-driven, latent variable approach was used to examine irritability and ADHD symptoms in a transdiagnostic pediatric sample (N = 489) with primary disruptive mood dysregulation disorder, ADHD, subclinical irritability symptoms, or no diagnosis. Using latent profile analyses, we identified 4 classes: high levels of both irritability and ADHD symptoms, high levels of irritability and moderate levels of ADHD symptoms, moderate levels of irritability and high levels of ADHD symptoms, and low levels of both irritability and ADHD symptoms. Confirmatory factor analysis operationalized phasic irritability and tonic irritability.
RESULTS: As expected, the 2 latent classes characterized by high overall irritability exhibited the highest levels of both phasic and tonic irritability. However, between these 2 high irritability classes, highly comorbid ADHD symptoms were associated with significantly greater phasic irritability than were moderately comorbid ADHD symptoms. In contrast, the 2 high irritability groups did not differ on levels of tonic irritability.
CONCLUSION: These findings suggest that phasic, but not tonic, irritability has a significant association with ADHD symptoms and that phasic and tonic might be distinct, though highly related, irritability dimensions. Future research should investigate potential mechanisms underlying this differential association. Published by Elsevier Inc.

Entities:  

Keywords:  ADHD; DMDD; aggression; irritability; latent variable analysis

Mesh:

Year:  2021        PMID: 33440203      PMCID: PMC9073575          DOI: 10.1016/j.jaac.2020.11.022

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   13.113


  45 in total

1.  A Double-Blind Randomized Placebo-Controlled Trial of Citalopram Adjunctive to Stimulant Medication in Youth With Chronic Severe Irritability.

Authors:  Kenneth Towbin; Pablo Vidal-Ribas; Melissa A Brotman; Andrew Pickles; Katherine V Miller; Ariela Kaiser; Aria D Vitale; Chana Engel; Gerald P Overman; Mollie Davis; Beth Lee; Cheri McNeil; Wanda Wheeler; Catherine H Yokum; Catherine T Haring; Alexandra Roule; Caroline G Wambach; Banafsheh Sharif-Askary; Daniel S Pine; Ellen Leibenluft; Argyris Stringaris
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2019-05-23       Impact factor: 8.829

Review 2.  Pediatric Irritability: A Systems Neuroscience Approach.

Authors:  Ellen Leibenluft
Journal:  Trends Cogn Sci       Date:  2017-03-06       Impact factor: 20.229

3.  Neural Correlates of Irritability in Disruptive Mood Dysregulation and Bipolar Disorders.

Authors:  Jillian Lee Wiggins; Melissa A Brotman; Nancy E Adleman; Pilyoung Kim; Allison H Oakes; Richard C Reynolds; Gang Chen; Daniel S Pine; Ellen Leibenluft
Journal:  Am J Psychiatry       Date:  2016-02-19       Impact factor: 18.112

4.  Empirically derived patterns of psychiatric symptoms in youth: A latent profile analysis.

Authors:  Katharina Kircanski; Susan Zhang; Argyris Stringaris; Jillian Lee Wiggins; Kenneth E Towbin; Daniel S Pine; Ellen Leibenluft; Melissa A Brotman
Journal:  J Affect Disord       Date:  2016-09-21       Impact factor: 4.839

5.  Do we need an irritable subtype of ADHD? Replication and extension of a promising temperament profile approach to ADHD subtyping.

Authors:  Sarah L Karalunas; Hanna C Gustafsson; Damien Fair; Erica D Musser; Joel T Nigg
Journal:  Psychol Assess       Date:  2018-10-25

6.  Is Emotional Lability Distinct From "Angry/Irritable Mood," "Negative Affect," or Other Subdimensions of Oppositional Defiant Disorder in Children With ADHD?

Authors:  Lu Liu; Wai Chen; Silia Vitoratou; Li Sun; Xiaoyan Yu; Gareth Hagger-Johnson; Zhaomin Wu; Li Yang; Qiujin Qian; Yufeng Wang
Journal:  J Atten Disord       Date:  2016-02-03       Impact factor: 3.256

7.  Treatment of children with attention-deficit/hyperactivity disorder (ADHD) and irritability: results from the multimodal treatment study of children with ADHD (MTA).

Authors:  Lorena Fernández de la Cruz; Emily Simonoff; James J McGough; Jeffrey M Halperin; L Eugene Arnold; Argyris Stringaris
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-10-18       Impact factor: 8.829

8.  Stepped Treatment for Attention-Deficit/Hyperactivity Disorder and Aggressive Behavior: A Randomized, Controlled Trial of Adjunctive Risperidone, Divalproex Sodium, or Placebo After Stimulant Medication Optimization.

Authors:  Joseph C Blader; Steven R Pliszka; Vivian Kafantaris; Carmel A Foley; Gabrielle A Carlson; Judith A Crowell; Brigitte Y Bailey; Colin Sauder; W Burleson Daviss; Christa Sinha; Thomas L Matthews; David M Margulies
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2020-01-30       Impact factor: 8.829

9.  The Affective Reactivity Index: a concise irritability scale for clinical and research settings.

Authors:  Argyris Stringaris; Robert Goodman; Sumudu Ferdinando; Varun Razdan; Eli Muhrer; Ellen Leibenluft; Melissa A Brotman
Journal:  J Child Psychol Psychiatry       Date:  2012-05-10       Impact factor: 8.982

Review 10.  The Status of Irritability in Psychiatry: A Conceptual and Quantitative Review.

Authors:  Pablo Vidal-Ribas; Melissa A Brotman; Isabel Valdivieso; Ellen Leibenluft; Argyris Stringaris
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-05-06       Impact factor: 8.829

View more
  6 in total

1.  Is the distinction between tonic and phasic irritability meaningful in 3-year-old children?

Authors:  Jamilah Silver; Sara J Bufferd; Lea R Dougherty; Brandon L Goldstein; Gabrielle A Carlson; Daniel N Klein
Journal:  Eur Child Adolesc Psychiatry       Date:  2022-05-06       Impact factor: 4.785

2.  Longitudinal network model of the co-development of temperament, executive functioning, and psychopathology symptoms in youth with and without ADHD.

Authors:  Sarah L Karalunas; Dylan Antovich; Patrick K Goh; Michelle M Martel; Jessica Tipsord; Elizabeth K Nousen; Joel T Nigg
Journal:  Dev Psychopathol       Date:  2021-12-07

3.  Cardiovascular reactivity as a measure of irritability in a transdiagnostic sample of youth: Preliminary associations.

Authors:  Reut Naim; Matthew S Goodwin; Kelly Dombek; Olga Revzina; Courtney Agorsor; Kyunghun Lee; Christian Zapp; Gabrielle F Freitag; Simone P Haller; Elise Cardinale; David Jangraw; Melissa A Brotman
Journal:  Int J Methods Psychiatr Res       Date:  2021-08-13       Impact factor: 4.182

4.  Is Irritability a Top Problem in Youth Mental Health Care? A Multi-informant, Multi-method Investigation.

Authors:  Spencer C Evans; Katherine A Corteselli; Audrey Edelman; Hannah Scott; John R Weisz
Journal:  Child Psychiatry Hum Dev       Date:  2022-01-22

5.  Characterizing the Neural Correlates of Response Inhibition and Error Processing in Children With Symptoms of Irritability and/or Attention-Deficit/Hyperactivity Disorder in the ABCD Study®.

Authors:  Ka Shu Lee; Jingyuan Xiao; Jiajun Luo; Ellen Leibenluft; Zeyan Liew; Wan-Ling Tseng
Journal:  Front Psychiatry       Date:  2022-03-04       Impact factor: 4.157

6.  Associations Between Chronic Irritability and Sensory Processing Difficulties in Children and Adolescents.

Authors:  Yuji Harima; Dai Miyawaki; Ayako Goto; Kaoru Hirai; Shoko Sakamoto; Hiroki Hama; Shin Kadono; Sayaka Nishiura; Koki Inoue
Journal:  Front Psychiatry       Date:  2022-04-28       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.